释 义 n. 乐伐替尼（一种酪氨酸激酶受体抑制剂）
例 句 Lenvatinib is an oral multi-kinase inhibitor approved for the treatment of adults with progressive, locally advanced or metastatic, differentiated thyroid carcinoma refractory to radioactive iodine.仓伐替尼是一种口服多激酶抑制剂，被批准用于治疗进展性、局部进展性或转移性、对放射性碘难治的分化型甲状腺癌。
作者： Chie Masak
The ultimate clinical goal of advanced cancer treatment is improvement of survival. Tyrosine kinase inhibitors (TKIs) were recently approved for radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) that is resistant to conventional therapies, since they have significant potential to improve survival in patients who previously had no more treatment strategies available. However, eligible patients are limited in clinical practice, making it difficult to accurately determine the efficacy of TKIs.